on discovering and developing novel therapeutics directed to fundamental biologic pathways thought to drive cancer's growth, resistance, recurrence and metastases in order to improve the treatment of solid tumor cancers.
Expertise in cancer biology, platform drug discovery technologies and sophisticated antibody engineering know-how have combined to generate a large internally discovered oncology pipeline
Six distinct clinical-stage anti-cancer drugs, several pre-clinical candidates, plus ongoing drug discovery efforts tackling challenging and unique targets sets us up for huge potential successes
Collaborations with partners provide validation of our scientific approach, access to commercial expertise and funding to advance our pipeline and enable strategic company growth
Delayed at least 20 minutes. Provided by eSignal.